Bacteria‐targeting Nanosilver‐Based Antibacterial Drugs for Efficient Treatment of Drug‐Resistant Bacterial‐Infected Keratitis

Yufei Zhang,Anran Li,Ye Zhang,Shihao Hong,Yun Xue,Xianhui Song,Jie Li,Siyuan Huang,Xinge Zhang

DOI: https://doi.org/10.1002/marc.202300379

IF: 5.006

2023-09-07

Macromolecular Rapid Communications

Abstract:Keratitis caused by drug‐resistant bacteria is a severe condition that can lead to corneal perforation and even blindness, making effective treatment a top priority amid growing antibiotic resistance. Eye drops for anti‐inflammatory treatment necessitate frequent administration of high doses throughout every day due to bacterial resistance resulting from antibiotic overuse and the low bioavailability of drugs. To overcome these issues, an antibacterial nanocomposite was prepared via conjugating random copolymers of galactose and 3‐(acrylamide)phenylboronic acid to the surface of silver nanoparticles. The customized nanocomposites trigger specific binding to bacteria, resulting in excellent retention of the drug on the ocular surface, resulting in rapid and powerful killing of bacteria and inhibition of bacterial proliferation. Due to its superior drug delivery capabilities to the ocular surface, the functionalized nanocomplex markedly amplifies the anti‐inflammatory efficacy, even at low doses. This effect is achieved by impeding immune cell infiltration and diminishing the synthesis of inflammatory mediators and cytokines, thereby suggesting enhanced healing properties for corneal inflammation. This study demonstrates a promising nanocomposite which is an effective and safe antibacterial strategy for bacterial keratitis with favorable prognostic and clinical conversion potential. This article is protected by copyright. All rights reserved

polymer science